Literature DB >> 9083562

Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions.

Z Nagy1, M M Esiri, A D Smith.   

Abstract

Recent studies, showing that cell cycle-related nuclear proteins p105 and Ki-67 are associated with Alzheimer's disease (AD)-related cytoskeletal pathology, suggested that these proteins, in addition to their functions in regulating the cell cycle, may have more specialised functions in the adult nervous system. In order to test this hypothesis we studied the expression of the cell cycle-related proteins Ki-67, pCNA and p53 in the hippocampi of 33 subjects, including some with AD or other neurodegenerative disorders and some with no neurological disease. By immunohistochemistry we found nuclear expression of Ki-67 in all subregions of the hippocampus, with the highest levels in the dentate gyrus. Both neurons and glial cells expressed this protein. The proportion of cells positive for Ki-67 and the distribution pattern varied considerably depending on the pathological diagnosis. Neuronal nuclear expression of Ki-67 was increased in AD but was also elevated in young Down's syndrome subjects and in those with Pick's disease. Expression of this protein was therefore not AD-specific. We did not find nuclear pCNA or p53 expressed in our patient groups. Contrary to previous studies AD-type neurofibrillary tangles were not labelled with any of the cell cycle markers used. The presence of nuclear Ki-67 expression indicates that some hippocampal neurons are not in the quiescent G0 phase but have re-entered the cell cycle. The absence of nuclear pCNA or p53 suggests that the cycle is arrested in G1. The significance of our findings and their relationship to the production of neurodegenerative cell death via an apoptotic mechanism are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9083562     DOI: 10.1007/s004010050617

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  66 in total

1.  DNA replication precedes neuronal cell death in Alzheimer's disease.

Authors:  Y Yang; D S Geldmacher; K Herrup
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

Review 2.  The role of cell cycle-mediated events in Alzheimer's disease.

Authors:  A K Raina; M J Monteiro; A McShea; M A Smith
Journal:  Int J Exp Pathol       Date:  1999-04       Impact factor: 1.925

Review 3.  Cell cycle events in neurons. Proliferation or death?

Authors:  X Zhu; A K Raina; M A Smith
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

4.  Induction of cell-cycle regulators in simian immunodeficiency virus encephalitis.

Authors:  K L Jordan-Sciutto; G Wang; M Murphy-Corb; C A Wiley
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 5.  Alzheimer's disease research enters a "new cycle": how significant?

Authors:  A Copani; M A Sortino; F Nicoletti; Stella A M Giuffrida
Journal:  Neurochem Res       Date:  2002-02       Impact factor: 3.996

Review 6.  Oxidative stress, cell cycle, and neurodegeneration.

Authors:  Jeffrey A Klein; Susan L Ackerman
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 7.  Pathological implications of cell cycle re-entry in Alzheimer disease.

Authors:  David J Bonda; Hyun-pil Lee; Wataru Kudo; Xiongwei Zhu; Mark A Smith; Hyoung-gon Lee
Journal:  Expert Rev Mol Med       Date:  2010-06-29       Impact factor: 5.600

8.  Neurotoxin-induced DNA damage is persistent in SH-SY5Y cells and LC neurons.

Authors:  Yan Wang; Phillip R Musich; Kui Cui; Yue Zou; Meng-Yang Zhu
Journal:  Neurotox Res       Date:  2015-03-01       Impact factor: 3.911

9.  Early induction of c-Myc is associated with neuronal cell death.

Authors:  Hyun-Pil Lee; Wataru Kudo; Xiongwei Zhu; Mark A Smith; Hyoung-gon Lee
Journal:  Neurosci Lett       Date:  2011-10-08       Impact factor: 3.046

Review 10.  Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease.

Authors:  Evelin L Schaeffer; Orestes V Forlenza; Wagner F Gattaz
Journal:  Psychopharmacology (Berl)       Date:  2008-10-14       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.